Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data
OrthoSpineNews
MAY 13, 2025
We intend that the product will be used for the non-surgical treatment of painful lumbosacral disc disorders or as a complementary therapeutic to a surgical procedure. In an outpatient procedure, BRTX-100 is to be injected by a physician into the patients damaged disc.
Let's personalize your content